Utility of PFA-100 closure time vs. optical aggregometry in assessing the efficacy of platelet membrane glycoprotein IIb/IIIa antagonists in vitro.

about

The effect of pre-analytical variables on light transmittance aggregometry in citrated platelet-rich plasma from healthy subjects.

P2860

Q42975065-E19B30AC-4124-4FE8-9220-9F4679C9BC88

P2860

Utility of PFA-100 closure time vs. optical aggregometry in assessing the efficacy of platelet membrane glycoprotein IIb/IIIa antagonists in vitro.

Item

http://www.wikidata.org/entity/Q46923683

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Utility of PFA-100 closure tim ...... IIb/IIIa antagonists in vitro.

@en

Utility of PFA-100 closure tim ...... IIb/IIIa antagonists in vitro.

@nl

type

Item

label

Utility of PFA-100 closure tim ...... IIb/IIIa antagonists in vitro.

@en

Utility of PFA-100 closure tim ...... IIb/IIIa antagonists in vitro.

@nl

prefLabel

Utility of PFA-100 closure tim ...... IIb/IIIa antagonists in vitro.

@en

Utility of PFA-100 closure tim ...... IIb/IIIa antagonists in vitro.

@nl

P1476

Utility of PFA-100 closure tim ...... IIb/IIIa antagonists in vitro.

@en

P2093

Danijel Kikelj

http://www.w3.org/2001/XMLSchema#string

Marija Sollner Dolenc

http://www.w3.org/2001/XMLSchema#string

Mojca Bozic

http://www.w3.org/2001/XMLSchema#string

Mojca Stegnar

http://www.w3.org/2001/XMLSchema#string

Petra Stefanic Anderluh

http://www.w3.org/2001/XMLSchema#string

P2860

Limited usefulness of the PFA-100 for the monitoring of ADP receptor antagonists--in vitro experience

Rapid assessment of glycoprotein IIb/IIIa blockade with the platelet function analyzer (PFA-100) during percutaneous coronary intervention

Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100

Clinical application of the PFA-100

PFA-100 and flow cytometry: can they challenge aggregometry to assess antiplatelet agents, other than GPIIbIIIa blockers, in coronary angioplasty?

Using the Platelet Function Analyzer-100 for monitoring aspirin therapy

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesis.

Platelet aggregation inhibition with glycoprotein IIb--IIIa inhibitors.

Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function.

P304

1542-1548

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1515/CCLM.2007.318

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5875043

http://www.w3.org/2001/XMLSchema#string

P698

17970708

http://www.w3.org/2001/XMLSchema#string

Utility of PFA-100 closure time vs. optical aggregometry in assessing the efficacy of platelet membrane glycoprotein IIb/IIIa antagonists in vitro.

about

P2860

P2860

Utility of PFA-100 closure time vs. optical aggregometry in assessing the efficacy of platelet membrane glycoprotein IIb/IIIa antagonists in vitro.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698